We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
-$10.5M
Cap. Flow
+$1.89M
Cap. Flow %
0.72%
Top 10 Hldgs %
18.95%
Holding
132
New
7
Increased
58
Reduced
39
Closed
13

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$4.91M
2
IONS icon
Ionis Pharmaceuticals
IONS
+$2.51M
3
PAYC icon
Paycom
PAYC
+$2.07M
4
KKR icon
KKR & Co
KKR
+$2.04M
5
UTHR icon
United Therapeutics
UTHR
+$1.83M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$3.21M
2
CERN
Cerner Corp
CERN
+$2.21M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.05M
4
ARE icon
Alexandria Real Estate Equities
ARE
+$1.95M
5
NFLX icon
Netflix
NFLX
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 28.24%
2 Healthcare 23.73%
3 Communication Services 9.87%
4 Financials 9.16%
5 Consumer Discretionary 9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTDR icon
76
Matador Resources
MTDR
$5.98B
$1.94M 0.74%
119,256
+5,761
+5% +$96.3K
REGN icon
77
Regeneron Pharmaceuticals
REGN
$72.9B
$1.93M 0.74%
7,074
-508
-7% -$150K
WDAY icon
78
Workday
WDAY
$41.9B
$1.91M 0.73%
11,302
-7,379
-40% -$1.42M
EGRX
79
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.9M 0.73%
33,725
-1,424
-4% -$80.1K
TWLO icon
80
Twilio
TWLO
$28.8B
$1.88M 0.72%
17,683
+5,704
+48% +$740K
VICR icon
81
Vicor
VICR
$8.28B
$1.88M 0.72%
64,090
+8,825
+16% +$272K
RARE icon
82
Ultragenyx Pharmaceutical
RARE
$2.5B
$1.88M 0.71%
44,133
+7,968
+22% +$433K
SFIX
83
Stitch Fix
SFIX
$566M
$1.87M 0.71%
101,941
+40,415
+66% +$939K
MPT
84
Medical Properties Trust
MPT
$2.88B
$1.87M 0.71%
95,849
– –
MMSI icon
85
Merit Medical Systems
MMSI
$4.74B
$1.86M 0.71%
61,121
+22,652
+59% +$916K
EXEL icon
86
Exelixis
EXEL
$14B
$1.84M 0.7%
102,270
+58,892
+136% +$1.19M
HSTM icon
87
HealthStream
HSTM
$861M
$1.84M 0.7%
70,888
– –
TREE icon
88
LendingTree
TREE
$561M
$1.81M 0.69%
5,888
+357
+6% +$122K
KURA icon
89
Kura Oncology
KURA
$788M
$1.8M 0.69%
122,273
+20,075
+20% +$357K
CLR
90
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1.79M 0.68%
58,496
+20,662
+55% +$698K
PEGA icon
91
Pegasystems
PEGA
$5.07B
$1.78M 0.68%
52,854
+5,054
+11% +$183K
XYZ
92
Block Inc
XYZ
$49B
$1.78M 0.68%
29,306
-11,205
-28% -$761K
FDX icon
93
FedEx
FDX
$73.2B
$1.77M 0.67%
12,188
– –
MDGL icon
94
Madrigal Pharmaceuticals
MDGL
$12.4B
$1.75M 0.67%
20,593
+2,445
+13% +$229K
WWE
95
DELISTED
World Wrestling Entertainment
WWE
$1.75M 0.67%
24,524
-5,925
-19% -$425K
EPAM icon
96
EPAM Systems
EPAM
$5.55B
$1.74M 0.66%
9,624
– –
OMER icon
97
Omeros
OMER
$835M
$1.74M 0.66%
105,815
-4,260
-4% -$73.1K
EEFT icon
98
Euronet Worldwide
EEFT
$3.16B
$1.7M 0.65%
11,856
+1,234
+12% +$191K
PEN icon
99
Penumbra
PEN
$12.6B
$1.69M 0.64%
12,799
+2,552
+25% +$395K
NBIX icon
100
Neurocrine Biosciences
NBIX
$18.3B
$1.67M 0.64%
18,549
-2,374
-11% -$222K
2 3
4
5 6

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
RC
Resolute Capital Greenville, South Carolina $247M AUM

Capital Impact Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Capital Impact Advisors held 132 positions worth $262M, down 3.8% from $273M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Capital Impact Advisors's Q3 2019 filing shows 7 new, 58 increased, 39 reduced and 13 closed positions. Its largest new stake was Microsoft: 35,722 shares worth $4.92M. The largest sale was UnitedHealth, an estimated $3.21M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Communication Services.

  • Capital Impact Advisors's largest Q3 2019 buy was Microsoft: 35,722 shares worth $4.92M.
  • Capital Impact Advisors added most to Ionis Pharmaceuticals in Q3 2019, an estimated $2.51M increase.
  • Capital Impact Advisors's biggest Q3 2019 reduction was Alphabet (Google) Class A, cutting an estimated $2.05M.
  • Capital Impact Advisors fully exited UnitedHealth in Q3 2019, selling an estimated $3.21M.
  • Capital Impact Advisors's ten largest holdings make up 19% of its $262M portfolio in Q3 2019.
  • Capital Impact Advisors opened 7 new positions and closed 13 in Q3 2019.
  • Capital Impact Advisors's portfolio value fell 3.8% quarter-over-quarter to $262M.

Based on Capital Impact Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.